EN
HI
Cohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
38.10 L
Market Cap
13634.69 CR
LTQ@LTP
215@356.40
ATP
357.93
Var Margin
35 %
Circuit Range
286.9-430.3
Delivery %
11.89 %
Value
136.37 CR
ASM/GSM
No
Market Lot
1
Summary
At 15 Apr, 2026 | 15:59, Cohance Lifesciences share price stands at ₹356.4, showing a 2.20% -0.61 for the day. The stock’s intraday movement has stayed between ₹350.10 and ₹367.70, while on a 52-week basis it has fluctuated from ₹266.70 to ₹1250.00.
In terms of trading activity, Cohance Lifesciences has recorded a volume of 3810051 shares, with a market capitalisation of ₹382567140. The stock’s Average Traded Price (ATP) stands at ₹35793, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 215,35640. The stock operates within a circuit range of ₹286.9-430.3, with a Value of ₹136.37 CR. The Delivery Percentage for the day is 11.89%. Additionally, Cohance Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Cohance Lifesciences Fundamentals
View MoreP/E Ratio
71.73
P/B Ratio
3.79
Div. Yield
0
Sector P/E
62.92
Sector P/B
3.41
Sec. Div. Yield
0.57
Cohance Lifesciences Resistance and Support
Pivot 360.78
Resistance
First Resistance
368.41
Second Resistance
378.23
Third Resistance
385.86
Support
First Support
350.96
Second Support
343.33
Third Support
333.51
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Limited
Cohance Lifesciences responded to an NSE query regarding increased trading volume. The company confirmed no pending undisclosed information affecting price/volume and attributed the movement to prevailing market conditions.
Apr 12 2026 23:04:00
Cohance Lifesciences Limited
COHANCE LIFESCIENCES appointed Sisir K. Mishra as Company Secretary, effective April 9, 2026. Mr. Mishra brings over two decades of experience in corporate secretarial, legal, and governance functions across diversified sectors.
Mar 30 2026 22:03:00
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Mr. Vivek Sharma | Executive Chairman |
| Dr. V Prasada Raju | Managing Director |
Cohance Lifesciences Similar Stocks
Granules India Ltd.
652.65
20.25 (3.20%)
Poly Medicure Ltd.
1472.40
19.30 (1.33%)
Jubilant Pharmova Ltd.
906.75
14.45 (1.62%)
Alembic Pharmaceuticals Ltd.
734.80
17.30 (2.41%)
Dr. Agarwal's Health Care Ltd.
446.45
13.25 (3.06%)
Rainbow Children's Medicare Ltd.
1265.00
-10.80 (0.85%)
Caplin Point Laboratories Ltd.
1735.60
48.50 (2.87%)
Alivus Life Sciences Ltd.
1064.90
18.65 (1.78%)
Sanofi Consumer Healthcare India Ltd.
4699.90
79.20 (1.71%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 356.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 71.73. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 3.79. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 62.92 & 3.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 13634.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1250.00 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
